ANTICOAGULANT DRUGS IN THE ELDERLY - VALUABLE IN SELECTED PATIENTS

被引：10

作者：

LOWE, GDO

机构：

来源：

BRITISH MEDICAL JOURNAL | 1988年 / 297卷 / 6658期

关键词：

D O I：

10.1136/bmj.297.6658.1260

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1260 / &

共 22 条

[11]

MORRIS GK, 1976, LANCET, V2, P869

[12]

NIH Consensus Development, 1986, JAMA, V256, P744

[13] DETERMINANTS OF ANTICOAGULANT CONTROL IN PATIENTS RECEIVING WARFARIN [J].

OMALLEY, K ;

STEVENSON, IH ;

WARD, CA ;

WOOD, AJJ ;

CROOKS, J .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (03) :309-314

[14]

SEVITT S, 1959, LANCET, V2, P981

[15]

STEWART ME, 1983, LANCET, V2, P479

[16] A RANDOMIZED CONTROLLED TRIAL OF A LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN) TO PREVENT DEEP-VEIN THROMBOSIS IN PATIENTS UNDERGOING ELECTIVE HIP-SURGERY [J].

TURPIE, AGG ;

LEVINE, MN ;

HIRSH, J ;

CARTER, CJ ;

JAY, RM ;

POWERS, PJ ;

ANDREW, M ;

HULL, RD ;

GENT, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (15) :925-929

[17]

TURPIE AGG, 1987, LANCET, V1, P523

[18] PREDICTORS OF BLEEDING DURING HEPARIN-THERAPY [J].

WALKER, AM ;

JICK, H .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (11) :1209-1212

[19]

1980, LANCET, V2, P989

[20]

1988, LANCET, V1, P275

← 1 2 3 →